Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome.

Autor: Achleitner, Martin¹ (AUTHOR), Mair, Nina K^2,3 (AUTHOR), Dänhardt, Juliane¹ (AUTHOR), Kardashi, Romina¹ (AUTHOR), Puhan, Milo A⁴ (AUTHOR), Abela, Irene A^2,5 (AUTHOR), Toepfner, Nicole⁶ (AUTHOR), With, Katja de⁷ (AUTHOR), Kanczkowski, Waldemar¹ (AUTHOR), Jarzebska, Natalia¹ (AUTHOR), Rodionov, Roman N¹ (AUTHOR), Wolf, Christine⁶ (AUTHOR), Lee-Kirsch, Min Ae⁶ (AUTHOR), Steenblock, Charlotte¹ (AUTHOR) charlotte.steenblock@ukdd.de, Hale, Benjamin G² (AUTHOR), Bornstein, Stefan R^1,8,9 (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Jan2024, Vol. 11 Issue 1, p1-5. 5p.

Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon.

Autor: Mair, Nina K.^1,2 (AUTHOR), Hale, Benjamin G.¹ (AUTHOR) hale.ben@virology.uzh.ch

Publikováno v: Scientific Reports. 9/13/2022, Vol. 12 Issue 1, p1-8. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.

Autor: Achleitner M; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Mair NK; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Life Science Zurich Graduate School, ETH and University of Zurich, Zurich, Switzerland., Dänhardt J; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kardashi R; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Puhan MA; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., Abela IA; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland., Toepfner N; Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., de With K; Division of Infectious Diseases, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kanczkowski W; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Jarzebska N; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Rodionov RN; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Wolf C; Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Lee-Kirsch MA; Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Steenblock C; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Hale BG; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Bornstein SR; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2023 Dec 19; Vol. 11 (1), pp. ofad641. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2024).